- Home
- BRKR vs CYTK Comparison
BRKR vs CYTK Comparison
Compare BRKR & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRKR
- CYTK
- Stock Information
- Founded
- BRKR 1960
- CYTK 1997
- Country
- BRKR United States
- CYTK United States
- Employees
- BRKR N/A
- CYTK N/A
- Industry
- BRKR Biotechnology: Laboratory Analytical Instruments
- CYTK Biotechnology: Pharmaceutical Preparations
- Sector
- BRKR Industrials
- CYTK Health Care
- Exchange
- BRKR Nasdaq
- CYTK Nasdaq
- Market Cap
- BRKR 5.7B
- CYTK 5.6B
- IPO Year
- BRKR 2000
- CYTK 2004
- Fundamental
- Price
- BRKR $36.70
- CYTK $31.02
- Analyst Decision
- BRKR Buy
- CYTK Buy
- Analyst Count
- BRKR 12
- CYTK 15
- Target Price
- BRKR $57.50
- CYTK $73.71
- AVG Volume (30 Days)
- BRKR 2.6M
- CYTK 2.4M
- Earning Date
- BRKR 05-07-2025
- CYTK 05-06-2025
- Dividend Yield
- BRKR 0.55%
- CYTK N/A
- EPS Growth
- BRKR N/A
- CYTK N/A
- EPS
- BRKR 0.52
- CYTK N/A
- Revenue
- BRKR $3,446,100,000.00
- CYTK $19,218,000.00
- Revenue This Year
- BRKR $6.37
- CYTK $24.01
- Revenue Next Year
- BRKR $4.64
- CYTK $698.33
- P/E Ratio
- BRKR $69.91
- CYTK N/A
- Revenue Growth
- BRKR 14.84
- CYTK 412.21
- 52 Week Low
- BRKR $34.10
- CYTK $29.31
- 52 Week High
- BRKR $72.94
- CYTK $61.38
- Technical
- Relative Strength Index (RSI)
- BRKR 43.87
- CYTK 39.05
- Support Level
- BRKR $34.98
- CYTK $30.02
- Resistance Level
- BRKR $37.97
- CYTK $31.27
- Average True Range (ATR)
- BRKR 1.41
- CYTK 1.40
- MACD
- BRKR 0.01
- CYTK 0.24
- Stochastic Oscillator
- BRKR 22.75
- CYTK 42.12
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
About CYTK Cytokinetics Incorporated
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.